Latest News - Switzerland, Viral hepatitis

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Wednesday, November 22, 2017

5:34:00 PM CET

Subscribe
RSS

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
lb
lo
lt
lv
mk
ml
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Country info

CH

Switzerland (CH)

All news about Switzerland

All news sources from Switzerland

CH

Quotes... Extracted quotes

Ludwig Kappos said: “These new analyses of data from the large controlled studies with OCREVUS help advance our understanding of how, in relapsing MS, the disease may progress independent of relapses. These insights have implications for daily decisions made together with patients,” External link

4-traders Friday, October 27, 2017 7:18:00 AM CEST

Sandra Horning said: “The data presented at ECTRIMS ACTRIMS demonstrate the commitment of our scientists and research partners to advance understanding of MS progression through ongoing analyses of the OCREVUS Phase III clinical trials,” External link

4-traders Monday, October 16, 2017 7:11:00 AM CEST

Al Kuwari said: “Viral hepatitis is considered a silent killer. An infected person may show limited or no symptoms. When there are symptoms, they include jaundice (yellowing of the skin and eyes), dark urine, extreme fatigue, nausea, vomiting, and abdominal pain,” External link

thepeninsulaqatar Tuesday, August 1, 2017 11:06:00 AM CEST

Al Kuwari said: “If a person is infected with hepatitis A and E, the infection will most likely go away on its own and without the ongoing liver disease. Hepatitis B and C, on the other hand, can become chronic and lead to cirrhosis and liver cancer,” External link

thepeninsulaqatar Tuesday, August 1, 2017 11:06:00 AM CEST

Al Kuwari said: “Viral hepatitis is considered a silent killer. An infected person may show limited or no symptoms. When there are symptoms, they include jaundice (yellowing of the skin and eyes), dark urine, extreme fatigue, nausea, vomiting, and abdominal pain,” External link

albawaba-en Monday, July 31, 2017 2:33:00 PM CEST

Al Kuwari said: “If a person is infected with hepatitis A and E, the infection will most likely go away on its own and without the ongoing liver disease. Hepatitis B and C, on the other hand, can become chronic and lead to cirrhosis and liver cancer,” External link

albawaba-en Monday, July 31, 2017 2:33:00 PM CEST

Gottfried Hirnschall said: “Sofosbuvir started out costing $84,000 for a three-month curative treatment. And the prices have come down even in high- income countries to lower levels. But in low- and middle-income countries the prices are now down to $250 and less. And that is exactly what is needed,” External link

business-standard Saturday, July 29, 2017 8:51:00 PM CEST

Daily number of articles in this category

Trend data not available for this selection.